Who are Protara Therapeutics, Inc.'s main suppliers?

Protara Therapeutics, Inc. (TARA) key suppliers include: THE-FEINSTEIN-INSTITUTE-FOR-MEDICAL-RESEARCH. View the full supplier network at chainsifter.com/chain/TARA.

Who are Protara Therapeutics, Inc.'s major customers?

Protara Therapeutics, Inc. (TARA) key customers include: Biodexa Pharmaceuticals Plc. View the full customer network at chainsifter.com/chain/TARA.

What sector is Protara Therapeutics, Inc. in?

Protara Therapeutics, Inc. (TARA) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

TARA Supply Chain: Protara Therapeutics, Inc. Suppliers & Customers

1Suppliers

1Customers

3Debt Items

17Related Chains

Protara Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
THE-FEINSTEIN-INSTITUTE-FOR-MEDICAL-RESEARCH	THE-FEINSTEIN-INSTITUTE-FOR-MEDICAL-RESEARCH	90%	As consideration for the license grant, we agreed to pay the Institute tiered royalties of between 1.0% and 1.5% of all net sales.

Protara Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
BDRX	Biodexa Pharmaceuticals Plc	72%	Reciprocal relationship from BDRX graph: l lawsuits challenging state authority to regulate prescription drug payment limits. Furthermore, in December 2020, the U.S. Supreme Court held unanimously th…

Protara Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
TARA-DEBT-12880	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2019-09-23.
TARA-DEBT-12879	Warrants outstanding: 1700000	90%	xbrl warrant detail from xbrl 2024-12-31.
TARA-DEBT	Debt stack $3.1M	90%	Market cache reports total debt of $3.1M.

Protara Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Protara Therapeutics, Inc..

Protara Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
TARA-OWNER-JANUS-HENDERSON-GROUP-PLC	JANUS HENDERSON GROUP PLC	90%	13F overlay lists JANUS HENDERSON GROUP PLC as top holder; 114 tracked holders.

Protara Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
SABS	SAB Biotherapeutics, Inc.	100.00	2
RXRX	Recursion Pharmaceuticals, Inc.	100.00	2
CRSP	CRISPR Therapeutics AG	100.00	2
RLAY	Relay Therapeutics, Inc.	100.00	2
COGT	Cogent Biosciences, Inc.	100.00	2
GSK	GSK plc	100.00	2
TPST	Tempest Therapeutics, Inc.	100.00	2
SABSW	SAB Biotherapeutics, Inc.	50.00	2
LGND	Ligand Pharmaceuticals Incorporated	50.00	2
ORANY	ORANGE	50.00	2
CNSP	CNS Pharmaceuticals, Inc.	50.00	2
CGON	CG Oncology, Inc.	50.00	2
PSTV	Plus Therapeutics, Inc.	50.00	2
PVLA	Palvella Therapeutics, Inc.	36.29	1	['spend']
BDRX	Biodexa Pharmaceuticals Plc	36.29	1	['customer']
SLN	Silence Therapeutics plc	14.78	2
MANU	Manchester	14.78	2

Protara Therapeutics, Inc. Supply Chain